These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 36630924)
1. Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes. Chen TK; Coca SG; Thiessen-Philbrook HR; Heerspink HJL; Obeid W; Ix JH; Fried LF; Bonventre JV; El-Khoury JM; Shlipak MG; Parikh CR; Am J Nephrol; 2022; 53(11-12):775-785. PubMed ID: 36630924 [TBL] [Abstract][Full Text] [Related]
2. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD. Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704 [TBL] [Abstract][Full Text] [Related]
3. Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study. Gutiérrez OM; Shlipak MG; Katz R; Waikar SS; Greenberg JH; Schrauben SJ; Coca S; Parikh CR; Vasan RS; Feldman HI; Kimmel PL; Cushman M; Bonventre JV; Sarnak MJ; Ix JH Am J Kidney Dis; 2022 Jun; 79(6):849-857.e1. PubMed ID: 34752914 [TBL] [Abstract][Full Text] [Related]
4. Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Schrauben SJ; Shou H; Zhang X; Anderson AH; Bonventre JV; Chen J; Coca S; Furth SL; Greenberg JH; Gutierrez OM; Ix JH; Lash JP; Parikh CR; Rebholz CM; Sabbisetti V; Sarnak MJ; Shlipak MG; Waikar SS; Kimmel PL; Vasan RS; Feldman HI; Schelling JR; J Am Soc Nephrol; 2021 Jan; 32(1):115-126. PubMed ID: 33122288 [TBL] [Abstract][Full Text] [Related]
5. The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury. Bullen AL; Katz R; Lee AK; Anderson CAM; Cheung AK; Garimella PS; Jotwani V; Haley WE; Ishani A; Lash JP; Neyra JA; Punzi H; Rastogi A; Riessen E; Malhotra R; Parikh CR; Rocco MV; Wall BM; Bhatt UY; Shlipak MG; Ix JH; Estrella MM Kidney Int; 2019 Aug; 96(2):470-479. PubMed ID: 31262489 [TBL] [Abstract][Full Text] [Related]
6. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388 [TBL] [Abstract][Full Text] [Related]
7. Changes in tubular biomarkers with dietary intervention and metformin in patients with autosomal dominant polycystic kidney disease: a post-hoc analysis of two clinical trials. Wang W; You Z; Steele CN; Gitomer B; Chonchol M; Nowak KL BMC Nephrol; 2024 Jun; 25(1):206. PubMed ID: 38918734 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants. Bullen AL; Katz R; Jotwani V; Garimella PS; Lee AK; Estrella MM; Shlipak MG; Ix JH Am J Kidney Dis; 2021 Sep; 78(3):361-368.e1. PubMed ID: 33857535 [TBL] [Abstract][Full Text] [Related]
9. Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease. Jotwani VK; Lee AK; Estrella MM; Katz R; Garimella PS; Malhotra R; Rifkin DE; Ambrosius W; Freedman BI; Cheung AK; Raphael KL; Drawz P; Neyra JA; Oparil S; Punzi H; Shlipak MG; Ix JH; Am J Nephrol; 2019; 49(5):346-355. PubMed ID: 30939472 [TBL] [Abstract][Full Text] [Related]
10. Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury: Findings From the ACCORD Trial Study Participants. Nadkarni GN; Chauhan K; Rao V; Ix JH; Shlipak MG; Parikh CR; Coca SG Am J Kidney Dis; 2019 Jan; 73(1):31-38. PubMed ID: 30291011 [TBL] [Abstract][Full Text] [Related]
11. Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children. Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Gonzalez MC; Coca S; Schrauben SJ; Waikar SS; Ramachandran VS; Shlipak MG; Warady B; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S; J Am Soc Nephrol; 2020 May; 31(5):1067-1077. PubMed ID: 32234829 [TBL] [Abstract][Full Text] [Related]
12. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure. Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793 [TBL] [Abstract][Full Text] [Related]
13. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children. Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Ix JH; Jogalekar MP; Coca S; Waikar SS; Shlipak MG; Warady BA; Vasan RS; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S; ; J Am Soc Nephrol; 2021 Oct; 32(10):2664-2677. PubMed ID: 34544821 [TBL] [Abstract][Full Text] [Related]
14. Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD. Amatruda JG; Katz R; Sarnak MJ; Gutierrez OM; Greenberg JH; Cushman M; Waikar S; Parikh CR; Schelling JR; Jogalekar MP; Bonventre JV; Vasan RS; Kimmel PL; Shlipak MG; Ix JH; Kidney Int Rep; 2022 Jul; 7(7):1514-1523. PubMed ID: 35812302 [TBL] [Abstract][Full Text] [Related]
15. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients. Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836 [TBL] [Abstract][Full Text] [Related]
16. Association of Urine Biomarkers of Kidney Tubule Injury and Dysfunction With Frailty Index and Cognitive Function in Persons With CKD in SPRINT. Miller LM; Rifkin D; Lee AK; Kurella Tamura M; Pajewski NM; Weiner DE; Al-Rousan T; Shlipak M; Ix JH Am J Kidney Dis; 2021 Oct; 78(4):530-540.e1. PubMed ID: 33647393 [TBL] [Abstract][Full Text] [Related]
17. Serially assessed bisphenol A and phthalate exposure and association with kidney function in children with chronic kidney disease in the US and Canada: A longitudinal cohort study. Jacobson MH; Wu Y; Liu M; Attina TM; Naidu M; Karthikraj R; Kannan K; Warady BA; Furth S; Vento S; Trachtman H; Trasande L PLoS Med; 2020 Oct; 17(10):e1003384. PubMed ID: 33052911 [TBL] [Abstract][Full Text] [Related]
18. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT. Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH; Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012 [TBL] [Abstract][Full Text] [Related]
19. Relationship between biomarkers of tubular injury and intrarenal hemodynamic dysfunction in youth with type 1 diabetes. Johnson MJ; Tommerdahl KL; Vinovskis C; Waikar S; Reinicke T; Parikh CR; Obeid W; Nelson RG; van Raalte DH; Pyle L; Nadeau KJ; Bjornstad P Pediatr Nephrol; 2022 Dec; 37(12):3085-3092. PubMed ID: 35286453 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study. Bhavsar NA; Köttgen A; Coresh J; Astor BC Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]